REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 13 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $153,012 | -3.7% | 31,355 | +15.6% | 0.00% | – |
Q2 2023 | $158,894 | +39.9% | 27,115 | 0.0% | 0.00% | – |
Q1 2023 | $113,612 | -14.5% | 27,115 | -13.2% | 0.00% | – |
Q4 2022 | $132,825 | +681.3% | 31,253 | +195.3% | 0.00% | – |
Q3 2022 | $17,000 | +41.7% | 10,584 | 0.0% | 0.00% | – |
Q2 2022 | $12,000 | -53.8% | 10,584 | 0.0% | 0.00% | – |
Q1 2022 | $26,000 | -16.1% | 10,584 | 0.0% | 0.00% | – |
Q4 2021 | $31,000 | -27.9% | 10,584 | 0.0% | 0.00% | – |
Q3 2021 | $43,000 | -15.7% | 10,584 | 0.0% | 0.00% | – |
Q2 2021 | $51,000 | – | 10,584 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
EMC Capital Management | 123,915 | $613 | 0.45% |
Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |